Several studies suggested that Rb1 can inhibit apoptosis, decrease the Aβ level, reduce tau phosphorylation, attenuate inflammation, or even reduce insulin resistance to prevent AD cognitive deficit [62,63,64]. This evidence concerns the gene MAPT and Alzheimer disease.